Form 4 Tracker
Christopher Thomas Giordano

Director, CEO · 2 filings · Latest: Sep 11, 2026

TENAX THERAPEUTICS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TENX
Christopher Thomas GiordanoDirector, CEOSep 15, 2026
Purchase
$1.824,850$8.8K22,174
TENX
Christopher Thomas GiordanoDirector, CEOSep 11, 2026
Purchase
$1.886,000$11.3K17,324
TENX
Christopher Thomas GiordanoDirector, CEOJul 13, 2026
Option Exercise
$5.888,719$51.3K11,324